Scadden David
Agios Pharmaceuticals, Inc. - Common Stock (AGIO) · Director
Scadden David is listed in filings as Director at Agios Pharmaceuticals, Inc. - Common Stock (AGIO). This profile follows SEC Form 4 activity through Nov 14, 2025, including sale activity. Recent filings connect the profile to Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO), Editas Medicine Inc (EDIT), and Carisma Therapeutics, Inc. (CARM). The current snapshot covers public activity from Jul 1, 2024 to Nov 14, 2025. Reported amounts are shown as $3.6K to $8.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $8.2k200 shares | SellOct 8, 2025 | $41.00 | $28.62 | |
| $8.0k200 shares | SellSep 30, 2025 | $40.00 | $28.62 | |
| $8.0k200 shares | SellAug 27, 2025 | $40.00 | $28.62 | |
| $56k1.4k shares | SellJul 10, 2025 | $40.00 | $28.62 | |
| $9.3k200 shares | SellDec 11, 2024 | $46.28 | $28.62 |